Preferred Label : fingolimod;

UMLS semantic type : T119 - Lipid; T121 - Pharmacologic Substance;

CAS number : 162359-56-0; 3QN8BYN5QF;

Is substance : O;

UNII : 3QN8BYN5QF;

InChIKey : KKGQTZUTZRNORY-UHFFFAOYSA-N;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3266944/fr/gilenya-fingolimod
2021
false
false
false
France
insurance, health, reimbursement
treatment outcome
administration, oral
fingolimod
adult
child
adolescent
multiple sclerosis, relapsing-remitting
pregnancy
abnormalities, drug-induced
teratogens
fingolimod
fingolimod
Chemical and Drug Induced Liver Injury
liver failure, acute
evaluation of the transparency committee
fingolimod
Fingolimod Hydrochloride
Fingolimod Hydrochloride
Fingolimod Hydrochloride

---
https://www.ema.europa.eu/en/medicines/human/EPAR/fingolimod-accord
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
drugs, generic
fingolimod
fingolimod
fingolimod
immunosuppressive agents
immunosuppressive agents
multiple sclerosis, relapsing-remitting
adult
child
adolescent
aged
administration, oral
continuity of patient care
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Fingolimod Hydrochloride
Fingolimod Hydrochloride

---
https://www.has-sante.fr/portail/jcms/c_2913088/fr/gilenya
2019
false
true
false
false
France
administration, oral
child
adolescent
treatment outcome
fingolimod
immunosuppressive agents
multiple sclerosis, relapsing-remitting
insurance, health, reimbursement
fingolimod
Fingolimod Hydrochloride
Fingolimod Hydrochloride
evaluation of the transparency committee
Fingolimod Hydrochloride

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60728597
2012
France
summary of product characteristics
package leaflet
capsules
fingolimod

---
Nous contacter.
07/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.